BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29272549)

  • 21. An integrative investigation of the therapeutic mechanism of Ainsliaea fragrans Champ. in cervicitis using liquid chromatography tandem mass spectrometry based on a rat plasma metabolomics strategy.
    Zhang X; He M; Lei S; Wu B; Tan T; Ouyang H; Xu W; Feng Y
    J Pharm Biomed Anal; 2018 Jul; 156():221-231. PubMed ID: 29729635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomics study of serum and urine samples reveals metabolic pathways and biomarkers associated with pelvic organ prolapse.
    Deng W; Rao J; Chen X; Li D; Zhang Z; Liu D; Liu J; Wang Y; Huang O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121882. PubMed ID: 31809960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
    Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
    J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomics driven analysis of artichoke leaf and its commercial products via UHPLC-q-TOF-MS and chemometrics.
    Farag MA; El-Ahmady SH; Elian FS; Wessjohann LA
    Phytochemistry; 2013 Nov; 95():177-87. PubMed ID: 23902683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolome of canine and human saliva: a non-targeted metabolomics study.
    Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
    Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Wu Q; Wang Y; Gu X; Zhou J; Zhang H; Lv W; Chen Z; Yan C
    J Sep Sci; 2014 Jul; 37(14):1728-35. PubMed ID: 24771673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UHPLC-MS-based metabolomics analysis on mice bearing neoplasm (H22) for hispidulin.
    Li F; Li X; Miao Y; Shan C; Yuan F; Ma C; Wang Q; Chen J; Chen Y
    J Pharm Biomed Anal; 2016 Jun; 125():310-8. PubMed ID: 27077962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.
    Kordalewska M; Macioszek S; Wawrzyniak R; Sikorska-Wiśniewska M; Śledziński T; Chmielewski M; Mika A; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():49-57. PubMed ID: 30999273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum metabolomics profiling and potential biomarkers of myopia using LC-QTOF/MS.
    Dai L; Yang W; Qin X; Li Y; Cao H; Zhou C; Wang Y
    Exp Eye Res; 2019 Sep; 186():107737. PubMed ID: 31325450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum metabolite profiling of ST-segment elevation myocardial infarction using liquid chromatography quadrupole time-of-flight mass spectrometry.
    Gundogdu G; Senol O; Demirkaya Miloglu F; Koza Y; Gundogdu F; Hacımüftüoğlu A; Abd El-Aty AM
    Biomed Chromatogr; 2020 Feb; 34(2):e4738. PubMed ID: 31677392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic study of corticosterone-induced cytotoxicity in PC12 cells by ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
    Zhang H; Zheng H; Zhao G; Tang C; Lu S; Cheng B; Wu F; Wei J; Liang Y; Ruan J; Song H; Su Z
    Mol Biosyst; 2016 Mar; 12(3):902-13. PubMed ID: 26775910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
    Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
    J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
    Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
    J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.